1 / 4

Sleep apnea devices

A large count of diagnosed sleep apnea patients along with the higher healthcare costs associated with untreated sleep are the factors that foster the market growth.

Download Presentation

Sleep apnea devices

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Sleep apnea devices market Rising awareness concerning the effects of untreated sleep apnea in regions such as North America and the benefit of disability tax credit for sleep apnea in Canada are the factors that are likely to boost the market growth. A large count of diagnosed sleep apnea patients along with the higher healthcare costs associated with untreated sleep are the factors that foster the market growth. Download the Sample Report @ http://bit.ly/2JYrhkX Irregular reimbursements along with inappropriate patient compliance and cost effective alternative treatments for sleep apnea are the factors that restrain the growth of the market. Rise in obesity and a large pool of VC funding along with Innovative product offering are the factors that offer abundant growth opportunities in this market. Companies invest on developing innovative sleep apnea devices and oral appliances market is also expected to create growth opportunities in the market. The sleep apnea diagnostic devices market is segmented based on products, types, end user and region. Based on the products, the market is segmented into polysomnography (PSG) devices, respiratory polygraphs, single-channel screening devices (pulse oximeters), actigraphy systems. The polysomnography (PSG) devices is further segmented into clinical PSG devices and ambulatory PSG devices, while single-channel screening devices (pulse oximeters, tabletop pulse oximeters and wrist-worn pulse oximeters. On the basis of types the sleep apnea therapeutic devices market is segmented into Positive Airway Pressure (PAP) device, facial interfaces, adaptive servo-ventilation (ASV), airway clearance systems and oxygen concentrators, accessories, oral appliances and alternate therapies. The positive airway pressure (PAP) device is segmented into CPAP devices, APAP devices and BPAP devices. The facial interfaces is segmented into masks, full-face masks, nasal masks and nasal pillow masks. The accessories is further segmented into pillows, mask, cleaning wipes, chin restraints and others while oral appliances is further segmented into mandibular advancement devices and tongue retaining device. The end-user is segmented into home care settings and sleep laboratories and hospitals. On the basis of geography, the market is segmented into North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA). Key industry players in this market are Philips Healthcare, Resmed, Inc., Fisher & Paykel Healthcare Ltd, Somnomed Limited, Compumedics Limited, Devilbiss Healthcare, BMC Medical Co., Ltd., Braebon Medical Corporation, Weinmann Medical Devices GmbH and Whole You, Inc. KEY BENEFITS FOR STAKEHOLDERS: The report provides a comprehensive analysis of current & future market trends, key market challenges and emerging avenues for the growth of this market across the globe.  The report offers latest technological innovations and the recent R&D developments. 

  2. The report offers an insight into competitive landscape in terms of new technological developments, untapped segments, and value chain analysis.  This report entails the detailed quantitative analysis of the current market and estimations through 2014 and 2020, which assists in identifying the prevailing market opportunities.  The report offers detailed segmentation and analyzes the key segments in terms of market size by value and volume and country-level analysis to provide an in-depth understanding of the market.  Porters Five Forces analysis is offered in the report along with highlighting bargaining power of buyers and suppliers.  The report offers strategic analysis of financial status of key market players, and highlights market share of key vendors.  The report offers information on the status of new projects along with offering investment feasibility analysis of the same.  KEY MARKET SEGMENTS: By Product Polysomnography (PSG) Devices  oClinical PSG Devices oAmbulatory PSG Devices Respiratory Polygraphs  Single-Channel Screening Devices (Pulse Oximeters) Handheld Pulse Oximeters  oFingertip Pulse Oximeters oTabletop Pulse Oximeters oWrist-Worn Pulse Oximeters oActigraphy Systems By Type Positive Airway Pressure (PAP) Device  oCPAP Devices oAPAP Devices oBPAP Devices Facial Interfaces 

  3. oMasks oFull-Face Masks oNasal Masks oNasal Pillow Masks Adaptive Servo-Ventilation (ASV)  Airway Clearance Systems  Oxygen Concentrators  oStationary Concentrators oPortable Concentrators Accessories  oPillows oMask Cleaning Wipes oChin Restraints oOthers Oral Appliances  oMandibular Advancement Devices oTongue Retaining Device Alternate Therapies  oLifestyle Changes oAcupuncture oPositional Therapy By End User Home Care Settings  Sleep Laboratories and Hospitals  By Region North America  Europe  Asia-Pacific  LAMEA 

  4. Key Company Profile Philips Healthcare  Resmed, Inc.  Fisher & Paykel Healthcare Ltd  Somnomed Limited  Compumedics Limited  Devilbiss Healthcare  BMC Medical Co., Ltd.  Braebon Medical Corporation  Weinmann Medical Devices GmbH  Whole You, Inc. 

More Related